543963 — Shelter Pharma Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapValue Trap

Annual income statement for Shelter Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2020 March 31st	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	PROSPECTUS	Interim Report	ARS
Standards:	IAS	IAS	IAS	—	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	301	225	301	362	400
Cost of Revenue
Gross Profit	17.7	13.4	42.1	99	111
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	300	224	272	292	317
Operating Profit	1.01	0.574	28.1	69.9	83.4
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	1.06	0.627	28.1	69.8	82.8
Provision for Income Taxes
Net Income After Taxes	0.803	0.413	20.6	52.1	62
Net Income Before Extraordinary Items
Net Income	0.803	0.413	20.6	52.1	62
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	0.803	0.412	20.6	52.1	62
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.069	0.036	1.78	5.08	5.36
Dividends per Share